Literature DB >> 28053236

CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer.

Stalin Chellappa1,2,3,4, Harald Hugenschmidt5,6, Morten Hagness1,2,3,5, Saranya Subramani1, Espen Melum3,7, Pål Dag Line5, Knut-Jørgen Labori6, Gro Wiedswang8, Kjetil Taskén1,2,3,4,9, Einar Martin Aandahl10,2,3,5.   

Abstract

CD8+ T cells that express retinoic acid-related orphan receptor (ROR)γt (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors. We investigated their phenotype and functional properties in relationship to the pathogenesis of human distal bile duct cancer (DBDC). DBDC patients had an elevated level of type 17 immune responses and the frequency of CD8+RORγt+ T cells (TC17 cells) was increased in peripheral blood. The CD8+RORγt+ T cells represented a highly activated subset and produced IL-17A in equal amount as CD4+RORγt+ T cells (TH17 cells). Most CD8+RORγt+ T cells coexpressed T-bet, a lineage transcription factor for TH1 and TC1 development, suggesting that CD8+RORγt+ T cells undergo plasticity toward a TC17/1-like phenotype with coproduction of IL-17A and INF-γ. In comparison with CD8+RORγt- T cells, the CD8+RORγt+ T cells had a higher level of TCR signaling and were terminally differentiated and exhausted. These cells also had impaired ability to re-express perforin after degranulation and reduced cytotoxic immune function. A subset of CD8+RORγt+ T cells expressing a low level of programmed cell death protein 1 and a high level of OX40 were associated with reduced patient survival. In conclusion, CD8+RORγt+ T cells are proinflammatory and functionally impaired and may contribute to the pathogenesis of DBDC.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28053236     DOI: 10.4049/jimmunol.1600061

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes.

Authors:  Snehaa V Seal; Mathilde Henry; Clémentine Pajot; Cyrielle Holuka; Danielle Bailbé; Jamileh Movassat; Muriel Darnaudéry; Jonathan D Turner
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

2.  A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186.

Authors:  Cameron J Herting; Matthew R Farren; Yan Tong; Ziyue Liu; Bert O'Neil; Tanios Bekaii-Saab; Anne Noonan; Christopher McQuinn; Thomas A Mace; Walid Shaib; Christina Wu; Bassel F El-Rayes; Safi Shahda; Gregory B Lesinski
Journal:  Cancer Immunol Immunother       Date:  2021-06-23       Impact factor: 6.968

3.  OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers.

Authors:  Yayi He; Xiaoshen Zhang; Keyi Jia; Rafal Dziadziuszko; Sha Zhao; Juan Deng; Hao Wang; Fred R Hirsch; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2019-08

4.  Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation.

Authors:  Nannan Sun; Congmin Yuan; Xiaojun Ma; Yonghui Wang; Xianfeng Gu; Wei Fu
Journal:  Molecules       Date:  2018-12-03       Impact factor: 4.411

5.  A prognostic nomogram for distal bile duct cancer from Surveillance, Epidemiology, and End Results (SEER) database based on the STROBE compliant.

Authors:  Ye-Yu Zhao; Si-Hai Chen; Qin-Si Wan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory.

Authors:  Keyong Sun; Runda Xu; Fuhai Ma; Naixue Yang; Yang Li; Xiaofeng Sun; Peng Jin; Wenzhe Kang; Lemei Jia; Jianping Xiong; Haitao Hu; Yantao Tian; Xun Lan
Journal:  Nat Commun       Date:  2022-08-23       Impact factor: 17.694

7.  Early-like differentiation status of systemic PD-1+CD8+ T cells predicts PD-1 blockade outcome in non-small cell lung cancer.

Authors:  Asma Khanniche; Yi Yang; Jie Zhang; Shiqing Liu; Liliang Xia; Huangqi Duan; Yaxian Yao; Bingrong Zhao; Guo-Ping Zhao; Chengping Hu; Ying Wang; Shun Lu
Journal:  Clin Transl Immunology       Date:  2022-07-27

8.  PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer.

Authors:  Yang Shen; Yongsheng Teng; Yipin Lv; Yongliang Zhao; Yuan Qiu; Weisan Chen; Lina Wang; Ying Wang; Fangyuan Mao; Ping Cheng; Daiyuan Ma; Yuan Zhuang; Quanming Zou; Liusheng Peng
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.